Inflammatory Bowel Disease Drugs Market Size
The Inflammatory Bowel Disease (IBD) Drugs Market, valued at USD 21.15 billion in 2023, is anticipated to grow to USD 27.65 billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.47% during the forecast period from 2024 to 2031. This growth is driven by increasing prevalence of inflammatory bowel diseases such as Crohn's disease and...